Document Detail

Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice.
MedLine Citation:
PMID:  23334328     Owner:  NLM     Status:  Publisher    
Little is known about chromatin mechanisms that regulate tumor-initiating cells that are proposed to be responsible for tumor recurrence and relapse. We have previously shown that Pygopus 2 (Pygo2), a chromatin effector and context-dependent Wnt signaling coactivator, regulates mammary gland development by expanding epithelial stem/progenitor cells. However, the role of Pygo2 in mammary tumorigenesis in vivo remains to be addressed. In this study, we show that epithelia-specific ablation of Pygo2 in MMTV-Wnt1 transgenic mice results in delayed mammary ductal elongation, but the hyperbranching phenotype, aberrant accumulation of stem/progenitor-like cells, and canonical Wnt signaling output are largely unaffected. Chronic loss of Pygo2 significantly delays mammary tumor onset in MMTV-Wnt1 females, whereas acute deletion of Pygo2 in MMTV-Wnt1 tumor cells leads to a significant decrease in their tumor-initiating capability upon transplantation. Finally, we provide evidence supporting a role for Pygo2 in modulating the lineage potential of MMTV-Wnt1 tumor initiating cells. Collectively, our results suggest that Pygo2 acts at a step downstream of mammary stem cell accumulation to facilitate transformation, and that it regulates the tumor initiating capacity and lineage preference of the already transformed mammary cells, in MMTV-Wnt1 mice. These findings offer valuable insights into our understanding of the molecular basis of heterogeneity within breast tumors.Oncogene advance online publication, 21 January 2013; doi:10.1038/onc.2012.620.
K Watanabe; M Fallahi; X Dai
Related Documents :
17881898 - A transgenic mouse model for high content, cell cycle phenotype screening in live prima...
3206108 - Establishment of highly metastatic clones without tumorigenicity derived from dunn oste...
15380508 - Mouse models of human cancer as tools in drug development.
21160808 - Immunohistochemical and molecular genetic analyses of multiple sporadic gastrointestina...
19570088 - Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolizatio...
6825078 - Effect of whole-body hyperthermia on cell survival, metastasis frequency, and host immu...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-21
Journal Detail:
Title:  Oncogene     Volume:  -     ISSN:  1476-5594     ISO Abbreviation:  Oncogene     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aurora kinase A mediates epithelial ovarian cancer cell migration and adhesion.
Next Document:  Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation.